Actionnariat et activité des initiés pour Innate Pharma S.A. (IPHA): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $2.01 |
| Capitalisation | $189M |
| Bourse | NASDAQ |
| Pays | FR |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $175.9M | $99.4M | $152.3M | $202.9M | $136.8M | $103.8M | $84.2M | $70.6M | $66.4M | $28.1M |
| Placements à Court Terme | $21.8M | $16.7M | $15.2M | $16.0M | $14.8M | $16.1M | $17.3M | $21.9M | $14.4M | $6.2M |
| Créances | $25.6M | $15.1M | $146.6M | $2.8M | $11.3M | $1.7M | $3.1M | $46.5M | $1.6M | $7.6M |
| Stocks | $513000 | $6.3M | 0 | $5.6M | $3.3M | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $230.1M | $137.5M | $319.6M | $237.6M | $173.3M | $138.3M | $139.8M | $148.0M | $85.7M | $46.7M |
| Immobilisations Corporelles | $9.1M | $10.7M | $10.2M | $11.7M | $11.7M | $10.2M | $8.5M | $6.3M | $5.1M | $4.4M |
| Goodwill | 0 | 0 | 0 | 0 | $1000 | $2000 | -$41.0M | 0 | 0 | 0 |
| Actifs Incorporels | $9.1M | $46.2M | $84.5M | $97.0M | $46.3M | $44.2M | $42.6M | $416000 | 0 | 0 |
| Actifs Totaux | $281.6M | $255.0M | $451.2M | $401.4M | $307.4M | $267.5M | $207.9M | $175.2M | $111.1M | $62.7M |
| Dettes Fournisseurs | $15.6M | $20.0M | $28.6M | $27.9M | $20.7M | $14.7M | $13.7M | $8.6M | $7.9M | $15.0M |
| Dette à Court Terme | $375000 | $429000 | $394000 | $1.5M | $1.4M | $29.9M | $1.3M | $8.5M | $8.4M | $8.5M |
| Passifs Courants | $76.4M | $73.9M | $196.7M | $121.8M | $45.5M | $79.9M | $41.3M | $39.6M | $33.0M | $36.6M |
| Dette à Long Terme | $1.1M | $2.4M | $2.0M | $14.1M | $14.2M | $11.5M | $38.9M | $30.6M | $22.2M | $13.7M |
| Passifs Totaux | $195.4M | $169.1M | $284.0M | $183.9M | $151.4M | $160.1M | $153.7M | $132.3M | $102.2M | $84.4M |
| Réserves | -$103.6M | -$152.0M | -$134.8M | -$155.7M | -$220.5M | -$272.2M | -$330.3M | -$336.9M | -$386.4M | -$435.4M |
| Capitaux Propres | $86.2M | $86.0M | $167.2M | $217.4M | $156.0M | $107.4M | $54.2M | $51.9M | $8.8M | -$21.7M |
| Dette Totale | $5.3M | $5.9M | $4.5M | $18.7M | $19.1M | $44.3M | $42.3M | $39.9M | $31.0M | $22.6M |
| Dette Nette | -$192.4M | -$110.2M | -$163.0M | -$200.1M | -$132.6M | -$75.6M | -$59.2M | -$52.6M | -$49.8M | -$11.7M |
| Fonds de Roulement | $153.6M | $63.6M | $122.9M | $115.8M | $127.8M | $58.4M | $98.5M | $108.4M | $52.8M | $10.1M |
Santé financière
| Dette / Capitaux propres | -1.04 |
| Ratio de liquidité | 1.27 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -11.35 |
Rentabilité
| Rentabilité des capitaux propres | 593.93% |
| Rentabilité du capital investi | -155.52% |
| Rentabilité des actifs | -78.41% |
| Marge brute | 100.00% |
| Marge opérationnelle | -2058.02% |
| Marge nette | -1764.51% |
Entreprises liées: APLT · CGEN · CRBP · CRDF · CYBN · ELTX · MIST
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de IPHA: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions